Jinfeng Yuan

Dr. Jinfeng Yuan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YTYanlin Tao
Yanlin Tao
JYJinfeng Yuan
Jinfeng Yuan
HZHouyuan Zhou
Houyuan Zhou
ZLZikang Li
Zikang Li
XYXiaomeng Yao
Xiaomeng Yao
XWXiaojun Wu
Xiaojun Wu

1 September 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
HPHao Pan
Hao Pan
HWHeng Wang
Heng Wang
YTYanlin Tao
Yanlin Tao
JYJinfeng Yuan
Jinfeng Yuan
SXSanbin Xu
Sanbin Xu
TLTe Liu
Te Liu
Among adult-onset motor neuron diseases, amyotrophic lateral sclerosis (ALS) is the most common. ALS involves the increasing loss of lower and upper motor neurons. Within a few years of onset, ALS causes patient death via progressive paralysis of respiratory muscles. However, the current drugs used to treat ALS, riluzole, edaravone, and dextromethorphan/quinidine, can only delay the progression of the disease and alleviate a small number of symptoms in some patients, and no completely effective treatment is available. Traditional Chinese medicine (TCM) has shown significant advantages in the treatment of ALS in China and Asia; however, the mechanism of its efficacy is unclear. This review discusses the pathogenetic hypothesis of ALS in detail from the level of neurons and glial cells and uses two current experimental animal models of ALS to design experimental strategies to study TCM treatment. We aim to provide a scientific explanation of the mechanism of the effect of TCM in the treatment of ALS, which will help clinicians and research scientists to accept the theory of TCM to treat ALS and promote the development of TCM modernization.

2 September 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CLChunqiu Liu
Chunqiu Liu
JYJinfeng Yuan
Jinfeng Yuan
PCPeipei Cheng
Peipei Cheng
TYTao Yang
Tao Yang
QLQian Liu
Qian Liu
HZhua zhou
hua zhou
Heart failure with preserved ejection fraction (HFpEF) is a multifactorial cardiovascular disorder characterized by diastolic dysfunction, systemic inflammation, and myocardial fibrosis. Emerging evidence indicates that macrophage polarization imbalance plays a central role in HFpEF pathogenesis. Traditional Chinese medicine (TCM) has demonstrated therapeutic potential in modulating macrophage activity through pathways such as NO/cGMP/PKG, TGF-β/Smads, and PI3K/Akt, thereby exerting anti-inflammatory, antifibrotic, and antioxidant effects. In this review, we conducted a literature search in PubMed, Google Scholar, Web of Science, and CNKI for studies published up to May 2025, using the terms “HFpEF”, “Traditional Chinese Medicine”, and “macrophage”. A total of 19 relevant studies were included. We highlight representative TCM metabolites and TCM formulas, such as resveratrol, Qishen Yiqi Pill, Shenfu Injection, etc. And we summarize their mechanisms in regulating M1/M2 macrophage polarization. Finally, we identify current challenges, including limited HFpEF-specific models and insufficient mechanistic validation, and propose directions for future research.